研究用腫瘤細胞系的質(zhì)量控制和要求課件_第1頁
研究用腫瘤細胞系的質(zhì)量控制和要求課件_第2頁
研究用腫瘤細胞系的質(zhì)量控制和要求課件_第3頁
研究用腫瘤細胞系的質(zhì)量控制和要求課件_第4頁
研究用腫瘤細胞系的質(zhì)量控制和要求課件_第5頁
已閱讀5頁,還剩29頁未讀 繼續(xù)免費閱讀

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領

文檔簡介

研究用腫瘤細胞系的質(zhì)量

控制和要求

中國醫(yī)學科學院基礎醫(yī)學研究所劉玉琴研究用腫瘤細胞系的質(zhì)量控制和要求SomeFactsabouttheuseofculturedcells--Nobelprize2001,Cellcycle2002,apoptosis2006,RNAInterference2007,homologousrecombinationandgenetargeting2008,HPV—cervicalca,HIV--aids2009,telomere&telomeraseNobelprizewinner,useinvitroculturedcellsfortheirresearches.研究用腫瘤細胞系的質(zhì)量控制和要求現(xiàn)代生命科學研究中培養(yǎng)細胞的使用越來越廣泛1969~2004:celluseincreasingsteadilyPapersusecellsincrease2~2.5Xbiology,pharmacologyandmedicine----tumorresearch不可少的研究材料、對象、工具Useofcontaminatedormisidentifiedcellsincrease10X研究用腫瘤細胞系的質(zhì)量控制和要求Commonproblemsmicrobiologicalcontaminationwithparticularrespecttomycoplasmainfections(incidenceofca.25%)cross-contaminationbyothercelllinesandmisidentificationormisclassification(incidenceofmorethan15%)acquisitionofgeneticandepigeneticvariationsduetoover-passagingofcelllinesleadingtoageneticdriftofcellculturesandtotheselectionofalteredsubclones.研究用腫瘤細胞系的質(zhì)量控制和要求Wherefrom?faultycellculturetechniques:sharedreagents,repeateduseofthesamepipetteduringre-feedingoperationsandmanipulationofmultipleculturesatthesametimewithoutadequateisolationofonecelltypefromanother.theintroductionoffalse,contaminatedorover-passagedcelllinesfromothersourcesintothecellculturelaboratory(35%)Mislabeling,lackofawarenessIntentionalco-cultivationduringpropagationofhumanstemorprimarycellsusingafeederlayerderivedfromanotherspecies研究用腫瘤細胞系的質(zhì)量控制和要求細胞交叉污染歷史回顧1968,ApparentHeLacellcontaminationofhumanheteroploidcelllines.Nature.217:750-7511974,HeLacesscontaminatingculturesaroundtheworld,Sciences184:10591981,Contaminatedcellcultures.Nature289:2271981,cross-contaminationofcellsinculture.Sciences.212(4493):226-52研究用腫瘤細胞系的質(zhì)量控制和要求細胞交叉污染歷史回顧1999,Falsehumanhematopoieticcelllins:cross-cantaminationsandmisinterpretations.Leukemia.13(10):1601-72003,Falseleukmia–lymphomacelllines:anupdateonover500celllines.Leukemia17,416-4262004,celllinecross-comtamination:howawareare…invitrocelldevbiolanim.40(7):211-52007,Casesofmistakenidentity.Sciences315:928-9312009,NaturecallsforglobaldatabaseofcelllineSTRprofiles研究用腫瘤細胞系的質(zhì)量控制和要求保藏機構公布的錯誤細胞1細胞系種屬細胞類型污染源種屬細胞類型數(shù)據(jù)來源207人前B白血病REH人前B白血病DSMZ2474/90人胃癌HT-29人結直腸癌DSMZ2957/90人胃癌HT-29人結直腸癌DSMZ3051/80人胃癌HT-29人結直腸癌DSMZADLC-5M人肺癌HELA/-S3人宮頸癌DSMZAV3人羊膜HeLa人宮頸癌ATCCBCC-1/KMC人基底細胞癌HELA/-S3人宮頸癌DSMZBM-1640人前列腺癌DU-145人前列腺癌DSMZC16人胚胎肺成纖維細胞(MRC-5克?。〩eLa人宮頸癌ECACC研究用腫瘤細胞系的質(zhì)量控制和要求保藏機構公布的錯誤細胞2CHANGLiver人胚胎肝上皮HeLa人宮頸癌ATCC;JCRBCOLO-818人黑色素瘤COLO800人黑色素瘤DSMZDAMI人巨核細胞HEL人紅系白血病DSMZECV304人內(nèi)皮T24人膀胱癌ATCCECV-304人正常內(nèi)皮T24人膀胱癌DSMZEJ人膀胱癌T24人膀胱癌ATCC;JCRBEPLC3-2M1人肺癌HELA/-S3人宮頸癌DSMZ;JCRBEPLC-65人肺癌HELA/-S3人宮頸癌DSMZF2-4E5人胸腺上皮SK-HEP-1人肝癌DSMZF2-5B6人胸腺上皮SH-HEP-1人肝癌DSMZFL人羊膜HeLa人宮頸癌ATCCGHE人星狀細胞瘤T-24人膀胱癌DSMZGirardiHeart豬成年心臟HeLa人宮頸癌ATCC研究用腫瘤細胞系的質(zhì)量控制和要求HAG人T-24人膀胱癌DSMZHEp-2人成年喉上皮HeLa人宮頸癌ATCCHMV-1人黑色素瘤HeLa-S3人宮頸癌DSMZHuL-1HeLa人宮頸癌JCRBIMC-2人顎骨癌HeLa-S3人宮頸癌DSMZIntestine407人小腸上皮HeLa人宮頸癌ATCCJ-111HeLa人宮頸癌JCRBJOSK-I人單核細胞白血病U-937人組織細胞淋巴瘤DSMZJOSK-K人單核細胞白血病U-937人組織細胞淋巴瘤DSMZJOSK-M人單核細胞白血病U-937人組織細胞淋巴瘤DSMZ保藏機構公布的錯誤細胞3研究用腫瘤細胞系的質(zhì)量控制和要求JOSK-S人單核細胞白血病U-937人組織細胞淋巴瘤DSMZJTC-17

HeLa人宮頸癌Yamakage(JCRB)KB人HeLa人宮頸癌ATCC;JCRBKO51K562人髓系白血病DSMZ;JCRBKOSC-3Ca9-22人JCRBL132人胚胎肺上皮HeLa人宮頸癌ATCCLR10.6人前B白血病NALM-6人前B白血病DSMZMaTu人乳腺癌HELA/-S3人宮頸癌DSMZMC-4000人乳腺癌HELA/-S3人宮頸癌DSMZMKB-1人T細胞白血病CCRF-CEM人T細胞白血病DSMZ保藏機構公布的錯誤細胞4研究用腫瘤細胞系的質(zhì)量控制和要求MKN28MKN74人JCRBMOLT-15人T細胞白血病CTV-1人單核細胞白血病DSMZMT-1人乳腺癌HELA/-S3人宮頸癌DSMZNCC16PHK16-0b人JCRBP1-1A3人胸腺上皮SK-HEP-1人肝癌DSMZP1-4D6人胸腺上皮SK-HEP-1人肝癌DSMZP39TSU人HL60人髓系白血病JCRBPBEI人前B白血病NALM-6人前B白血病DSMZPSV811人成纖維WI38人成纖維JCRBRAMAK-1人肌肉滑膜T-24人膀胱癌DSMZ保藏機構公布的錯誤細胞5研究用腫瘤細胞系的質(zhì)量控制和要求SBC-2人膀胱癌HELA/-S3人宮頸癌DSMZSBC-7人膀胱癌HELA/-S3人宮頸癌DSMZSCLC-16H人SCLCSCLC-21/22H人SCLCDSMZSCLC-24H人SCLCSCLC-21/22H人SCLCDSMZSNB-19U251MG人膠質(zhì)瘤ATCCSPI-801人T細胞白血病K562人髓系白血病DSMZSPI-802人T細胞白血病K562人髓系白血病DSMZTK-1人?U251MG人膠質(zhì)瘤JCRBTMH-1IHH-4人JCRBWISH人新生羊膜上皮HeLa人宮頸癌ATCC保藏機構公布的錯誤細胞6研究用腫瘤細胞系的質(zhì)量控制和要求DSMZ德國細胞庫550leukemiaandlymphomacelllinessubmitted59/395(15%)byoriginators23 /155(15%)bysecondarysources研究用腫瘤細胞系的質(zhì)量控制和要求交叉污染細胞使用的后果Erroneousresults:WastedresearchmoneyPotentialdelayindiscovery研究用腫瘤細胞系的質(zhì)量控制和要求錯誤細胞使用2000-2004:19/Int407;45/WISH;59/Changliver;470/Hep-2;556/KB;2004(Buehring),pubmedsearch220publicationsinvolved,32%useHeLacells,33%testedforauthenticity,35%getcellsfromotherlabs.NCIpanelof60celllineswereusedforanticancerdrugevaluation.AmongthemADR-RESisacutallyOVCAR-8.Ithadbeenusedinabout300papers.研究用腫瘤細胞系的質(zhì)量控制和要求HeLacervicalcancercellsInt-407(describedas“non-transformedintestinalepithelialcells”)inBr.J.Cancer101,1596(2009),EMBOJ.22,5003(2003)andJ.Biol.Chem.280,13538(2005)WISH(describedas“non-transformedamnioticepithelialcells”)inMol.Pharmacol.69,796(2006),Endocrinology147,2490(2006)andJ.Biol.Chem.278,31731(2003)Changliver(describedas“normallivercells”)inOncogene28,3526(2009),Proteomics14,2885(2008)andJ.Biol.Chem.279,28106(2000)HEp-2(describedas“l(fā)aryngealcancer”)inInvestig.NewDrugs26,111–118(2008),Carcinogenesis29,1519(2008)andJ.Biol.Chem.283,36272(2008)KB(describedas“oralcancer”)inBiochem.Pharmacol.73,1901–1909(2007),Clin.CancerRes.14,8161(2008)andJ.Biol.Chem.280,23829(2005)HeLa,Int-407andHEp-2cellswereusedasthreedistinctcelllinesinthesamestudyinCancerRes.69,632(2009)研究用腫瘤細胞系的質(zhì)量控制和要求Ecv-304,“人臍靜脈內(nèi)皮細胞”日本實驗室建立,ATCC、DSMZ等機構有保藏,在1999—2000年,經(jīng)STR檢測,證明為T24(膀胱癌),各自網(wǎng)站有公布。在實驗室間廣泛傳播,2006y,全世界600余論文,利用該細胞進行研究,2/3在中國。Why?Donotknow?NoothersuitablecellularmodelExpensieve,cannotafford,havetocompromise研究用腫瘤細胞系的質(zhì)量控制和要求Ecv-304/T24研究用腫瘤細胞系的質(zhì)量控制和要求對細胞質(zhì)量的要求2007.10,Goslar,Germany,11ICCCScientistfromATCCproposed:(1)fundingagencies,gov.orprivaterequirecelllineauthenticationasaconditionfortheawardofgrantandcontractsfunds.(2)keyscientificJ…asaconditionforpublication.(3)conference,workshopand/ortraining.(4)labheadsbeencouragedtoensureQCmeasures.Authentic,WellcharacterizedTheproblemofSub-culturing研究用腫瘤細胞系的質(zhì)量控制和要求NIHNOTICE2007.12,RequirecellanthenticationForgrantForpaper研究用腫瘤細胞系的質(zhì)量控制和要求雜志及細胞使用者的要求

Examples1Thp-1,2009-1-5celllineauthentication,characterizationandfreedomfromcontaminationThisisanimportantissue,towhichauthorsshouldpayparticularattention.Itistheauthors'responsibilitytoensurethatcelllinesusedinanystudy(andthemajoritydoinvolvethem)arecertifiedasbeingthedesignatedtype,thattheyhavebeencheckedtoensuretheyarefreeofcontamination(e.g.mycoplasma),andthattheyhavebeenusedfromyoungstock.Thesearethethreecriteriauponwhichgoodpracticeisbased,assetoutintheUKCCCGuidelinesontheuseofcelllines().AttentionshouldbepaidtothisintheMaterialandMethodssection,andauthorsomittingtoincludeevidenceofgoodpracticewillfindthattheirarticlesmaybedelayeduntilsuchguaranteesaregiven.研究用腫瘤細胞系的質(zhì)量控制和要求Example2,ReportingonCellLineUseinAACRJournalsNEW!EFFECTIVEJULY1,2009

AACRstronglyencouragestheauthenticationofcelllinesusedintheresearchreportedinitsjournals.Ifcelllineswereusedintheresearch,astatementaddressingthefollowingpointsmustbeincludedinthe"MaterialsandMethods"section:1.

Fromwhereandwhenthecellswereobtained2.

Whetherthecelllineshavebeentestedandauthenticated3.

Themethodbywhichthecellsweretested4.

Howandwhenthecellswerelasttested研究用腫瘤細胞系的質(zhì)量控制和要求AACRJournalsCancerResearchClinicalCancerResearchCancerEpidemiology,Biomarkers&Prevention,

CEBPCancerPreventionResearchMolecularCancerResearchMolecularCancerTherapeuticsCancerReviewsOnlinePreventionPortal研究用腫瘤細胞系的質(zhì)量控制和要求Example2—shelflifeIfcellswereobtaineddirectlyfromacellbankthatperformscelllinecharacterizationsandpassagedintheuser'slaboratoryforfewerthan6

monthsafterreceiptorresuscitation,re-authorizationisnotrequired.Inthesecases,pleaseincludethemethodofcharacterizationusedbythecellbank.Ifcellswereobtaineddirectlyfromacellbankthatperformscelllinecharacterizationsandpassagedintheuser'slaboratoryforfewerthan6

monthsafterreceiptorresuscitation,re-authorizationisnotrequired.Inthesecases,pleaseincludethemethodofcharacterizationusedbythecellbank.研究用腫瘤細胞系的質(zhì)量控制和要求KeymilestonesintheefforttoaddresscelllinemisidentificationHelacelllineestablishedfromHenriettaLacksATCC,AmericanTypeCultureCollection.NIHNationalInstitutesofHealth.STR,ShortTandemRepeatInterspeciescross-ContaminationshownATCCstartsCuratingcelllinesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesNelson-Rossconfirms&estendsStanGartler’sfindingsJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantes1981-2005crossContaminationspreedsBeyongdHeLacellsNIHterminatescontractofNelson-RossNIHissuesguidelinesToavoidtheuseofmisidentifiedcelllinesRolandNardonestartstheSecondcrusadeagsinstCorsscontaminationNaturecallsforaGlobaldatabaseofCelllinesSTRprofies1952195819621966197419801981200520072009HelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesNelson-Rossconfirms&estendsStanGartler’sfindingsHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesNelson-Rossconfirms&estendsStanGartler’sfindingsHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesNelson-Rossconfirms&estendsStanGartler’sfindingsHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllines1981-2005crossContaminationspreedsBeyongdHeLacellsNelson-Rossconfirms&estendsStanGartler’sfindingsHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesNIHissuesguidelinesToavoidtheuseofmisidentifiedcelllines1981-2005crossContaminationspreedsBeyongdHeLacellsNelson-Rossconfirms&estendsStanGartler’sfindingsHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllines1952195819621966197419801981200520072009Interspeciescross-Contaminationshown1952195819621966197419801981200520072009StanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009StanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009JohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009JohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009NIHterminatescontractofNelson-RossJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009NIHterminatescontractofNelson-RossJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009RolandNardonestartstheSecondcrusadeagsinstCorsscontaminationNIHterminatescontractofNelson-RossJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009RolandNardonestartstheSecondcrusadeagsinstCorsscontaminationNIHterminatescontractofNelson-RossJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009NaturecallsforaGlobaldatabaseofCelllinesSTRprofiesRolandNardonestartstheSecondcrusadeagsinstCorsscontaminationNIHterminatescontractofNelson-RossJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981200520072009NIHissuesguidelinesToavoidtheuseofmisidentifiedcelllines1981-2005

crossContaminationspreedsBeyongdHeLacellsNelson-Rossconfirms&estendsStanGartler’sfindingsHelacelllineestablishedfromHenriettaLacksATCCstartsCuratingcelllinesNaturecallsforaGlobaldatabaseofCelllinesSTRprofiesRolandNardonestartstheSecondcrusadeagsinstCorsscontaminationNIHterminatescontractofNelson-RossJohnMaddoxdescribesIndividuallikeNelson-RossAsself-appointedvigilantesStanGartlershowsintraspeciesCross-contaminationbetweenHumancelllinesInterspeciescross-Contaminationshown1952195819621966197419801981

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論